Cycloguanil embonate is a prodrug of cycloguanil, an antifolate used in combination with pyrimethamine to treat malaria. It is an antimalarial drug used in combination with other drugs, usually pyrimethamine, to treat malaria. Cycloguanil embonate is a prodrug of cycloguanil, which is also an antifolate. When administered, cycloguanil embonate is rapidly metabolized to cycloguanil and then further metabolized to its active form, cycloguanil hydroxychloroquine. When used in combination with other drugs, such as pyrimethamine, cycloguanil embonate provides a more reliable and effective antimalarial protection.
Cycloguanil embonate is a medication used to prevent malaria, a serious illness caused by a parasite that enters the body through the bite of an infected mosquito. It is typically used in combination with another antimalarial medication, such as atovaquone.
Cycloguanil embonate is available as a tablet taken by mouth. It is usually started 1 to 2 days before travel to an area with malaria and continued daily for 7 days after leaving the area.
Common side effects of cycloguanil embonate include diarrhea, abdominal pain, vomiting, and headache. It can also cause dizziness, so it is important to be cautious when driving or operating machinery.
Cycloguanil embonate is not suitable for everyone, including people with certain medical conditions or who are taking other medications. It is important to talk to your doctor about the risks and benefits of taking cycloguanil embonate before you start taking it.
Here are some additional things to know about cycloguanil embonate:
- It is not effective in treating malaria once you have it.
- It is not a substitute for insect repellent or other measures to prevent mosquito bites.
- It is important to continue taking cycloguanil embonate for the full prescribed course, even if you start to feel better.